|
|
 |
The Trust has been established to
raise funds for research into the treatment of Late Infantile Battens
– also known as CLN2.
The development of therapies will directly benefit 500 children that are diagnosed with this devastating disease throughout the world and be a potential cure for around another 40 genetic disorders, saving the lives of thousands of children. Jordan’s compelling
story is what inspired us to establish the Jordan Jay Trust. |